Zura Bio names Robert Lisicki as COO, Kiran Nistala as CMO

Zura Bio (ZURA) announced the appointments of Robert Lisicki as President and COO, and Kiran Nistala, MBBS, PhD, as Executive Vice President Development and Chief Medical Officer, to the Executive Leadership Team. Lisicki will be responsible for developing and driving the business plan and strategic initiatives as Zura Bio builds a leading immunology company. Dr. Nistala will be responsible for the development strategy of prioritized pipeline products. Lisicki and Dr. Nistala have successfully worked on or led in the development of multiple drugs within the auto-immune therapeutic area. These executives position Zura Bio to deliver on the promise of their innovative medicines for patients in need of better clinical outcomes. . Lisicki served as the Chief Commercial Officer at Arena Pharmaceuticals, a prominent biopharmaceutical company acquired by Pfizer (PFE) for $6.7B in 2022. Dr. Nistala recently held the role of Vice President of late-stage clinical development in Immunology at AstraZeneca (AZN), where he was instrumental to their therapeutic build in autoimmune disease.